This is not commonly done. For about half the cases, interstitial cystitis goes away by itself. Most of those who need treatment find relief and get their lives back to normal. Treatment is mainly ...

Also known as interstitial cystitis (IC), painful bladder ... There’s currently no cure for PBS, but treatment can help manage symptoms. Researchers are still determining what causes PBS.

mCRPC Treatment A. Oliver Sartor, MD PSMA-Targeted Therapy Advanced Prostate Cancer Zachary Klaassen, MD, MSc Disparities: Social Determinants of Health Disparities: Social Determinants of Health ...

The "absolute best" interstitial cystitis treatment is pelvic floor physical therapy, says Dr. Boone. "A physical therapist can examine where pelvic floor muscles are tight and show you which ...

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

measures of interstitial lung disease (ILD) are different, and to understand how they change, in patients with scleroderma-related ILD who receive drug therapy versus placebo. Methods HRCT images were ...

Experts also presented real-life case studies to highlight best practices and discussed how ILDs can co-occur with other chronic conditions, emphasizing the need for a multidisciplinary approach to ...

Chronic pelvic floor pain can be a debilitating condition that significantly impacts quality of life Whether caused by trauma muscle dysfunction or underlying medical conditions pelvic floor pain can ...

Suplatast tosilate is an an immunoregulatory compound. It is formulated as hard gelatin capsules and dry syrup for oral route of administration. It is under development for idiopathic pulmonary ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

Suplatast tosilate is under clinical development by Melius Pharma and currently in Phase II for Idiopathic Pulmonary Fibrosis.